keyword
Keywords Cholangiocarcinoma AND unresec...

Cholangiocarcinoma AND unresectability AND CT

https://read.qxmd.com/read/34701984/an-imaging-feature-from-pre-therapy-computed-tomography-ct-scans-correlates-with-pathological-and-the-clinical-outcomes-in-patients-pts-with-intrahepatic-cholangiocarcinoma-icca
#21
JOURNAL ARTICLE
M Zaid, F Carapeto, A Dai, C P Thunshelle, D Elganainy, K Sun, C Grassberger, L N Kwong, S Lee, T Newhook, H S Tran Cao, J N Vauthey, M Javle, E J Koay
PURPOSE/OBJECTIVE(S): Intrahepatic cholangiocarcinoma (iCCA) remains a highly lethal disease. Biomarkers are needed to identify pts who may benefit from specific therapeutic strategies. Here, we hypothesized that imaging features derived from pre-therapy CT are associated with histopathological and clinical outcomes. MATERIALS/METHODS: Retrospectively, we identified 60 pts with localized iCCA (24 M, 36 F, median age 65 [range 26-84]), who received upfront resection as a discovery cohort (D1) and 87 pts with locally advanced iCCA (49 M, 38 F, median age 64 [range 30-88]) who received chemo and radiation therapy as a validation cohort (D2)...
November 1, 2021: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/34611210/assessment-of-radiation-sensitivity-of-unresectable-intrahepatic-cholangiocarcinoma-in-a-series-of-patients-submitted-to-radioembolization-with-yttrium-90-resin-microspheres
#22
JOURNAL ARTICLE
Tommaso Depalo, Antonio Claudio Traino, Irene Bargellini, Giulia Lorenzoni, Elena Bozzi, Caterina Vivaldi, Rocco Lamastra, Gianluca Masi, Roberto Cioni, Giuseppe Boni, Duccio Volterrani
Radioembolization is a valuable therapeutic option in patients with unresectable intrahepatic cholangiocarcinoma. The essential implementation of the absorbed dose calculation methods should take into account also the specific tumor radiosensitivity, expressed by the α parameter. Purpose of this study was to retrospectively calculate it in a series of patients with unresectable intrahepatic cholangiocarcinoma submitted to radioembolization. Twenty-one therapeutic procedures in 15 patients were analysed. Tumor absorbed doses were calculated processing the post-therapeutic 90 Y-PET/CT images and the pre-treatment contrast-enhanced CT scans...
October 5, 2021: Scientific Reports
https://read.qxmd.com/read/34498568/alpps-procedure-the-new-frontier-in-advanced-liver-surgery-single-centre-experience-and-literature-review
#23
REVIEW
Adrian Hotineanu, Serghei Burgoci, Eduard Bortă
Introduction: Presentation of the first experience of a liver surgery center in applying an innovative procedure - ALPPS (Associating Liver Partition and Portal vein ligation for Staged hepatectomy) for massive liver tumors. This medod has been performed in the surgery clinic 2 since 2018 in patients with massive primary or metastatic liver tumors, whose future residual liver volume is considered too small to perform curative liver resection safely. Until recently, these conditions assigned large tumors occupying more than 75-90% of the liver to the group of unresectable tumors...
August 2021: Chirurgia
https://read.qxmd.com/read/34483694/non-operative-management-of-bronchobiliary-fistula-due-to-proximal-migration-of-biliary-stent-in-a-patient-with-unresectable-klatskin-tumor
#24
Ievgen Tsema, Viktor Slobodianyk, Dmytro Rahushyn, Denys Myrhorodskiy, Oleh Yurkiv, Andrii Dinets
INTRODUCTION: One of the methods for the biliary tree decompression in the case of Klatskin tumor is transpapillary stenting, which could be completed by stent migration in 4% to 10% of cases. Approximately half of the stent migrations are in the proximal direction. In this study, we reported a rare case of proximal trans-diaphragmatic stent migration to the lower lobe of the right lung with the formation of a biliary-bronchial fistula (BBF). CASE PRESENTATION: A 60-year-old woman was diagnosed with hilar cholangiocarcinoma (type 3B by Bismuth-Corlette) complicated by posthepatic jaundice...
2021: Clinical Medicine Insights. Case Reports
https://read.qxmd.com/read/34276849/klatskin-tumor-presenting-as-unresectable-perihilar-hepatic-mass-a-case-report
#25
Thierry Romeo Yehouenou Tessi, Behyamet Onka, Maniani Abdel Ilah Drissi, Hounayda Jerguigue, Rachida Latib, Youssef Omor
Cholangiocarcinoma is a rare liver tumor with three types: intrahepatic, extrahepatic, and perihilar, which alone account for about 50% of cases. The diagnosis is late with a poor prognosis. Imaging through Bili MRI and CT scan plays an essential role in the classification and staging of tumors for therapeutic management. We report the case of a 62-year-old woman, received for cholestasis syndrome and weight loss in whom CT and MRI found a hepatic hilar mass. The diagnosis of Klatskin's tumor was retained with a histological finding of adenocarcinoma...
September 2021: Radiology Case Reports
https://read.qxmd.com/read/34244041/magnetic-resonance-image-guided-hypofractionated-ablative-radiation-therapy-for-extrahepatic-cholangiocarcinoma-plan-adaptation-in-changing-anatomy
#26
Sebnem Egriboyun, Gamze Ugurluer, Gorkem Gungor, Teuta Zoto Mustafayev, Bahattin Cicek, Gokhan Demir, Banu Atalar, Enis Ozyar
Extrahepatic cholangiocarcinoma is an aggressive malignancy of biliary duct epithelium which typically has a poor prognosis. Although surgical resection improves overall survival, many patients are deemed medically inoperable or have unresectable tumors. Herein, we report a case of an 84-year-old Caucasian male who was diagnosed with medically inoperable extrahepatic cholangiocarcinoma. Magnetic resonance image-guided hypofractionated ablative radiotherapy was administered which has the advantages of superior soft tissue resolution, better visualization of the target and organ at risk, daily online adaptive planning and continuous cine MR tracking of the target during irradiation...
January 2021: Medical Dosimetry: Official Journal of the American Association of Medical Dosimetrists
https://read.qxmd.com/read/34241805/chemotherapy-with-gemcitabine-for-unresectable-intrahepatic-cholangiocarcinoma-in-a-patient-undergoing-maintenance-hemodialysis
#27
JOURNAL ARTICLE
Kotaro Matsumoto, Kanji Okamoto, Yuta Namura, Tomohiro Kikuyama, Go Saito, Takako Adachi, Ayako Watanabe, Hiromichi Tsunashima, Nobuhiro Katsukura, Takayuki Tsujikawa, Kentaro Kikuchi, Katsuyuki Matsui, Shinpei Doi
A 56-year-old man with chronic renal failure due to diabetic nephropathy had received maintenance dialysis (every 4 h, three times/week). A hypoechoic tumor measuring 67 × 50 mm in the right lobe of the liver was discovered following routine abdominal ultrasonography. Dynamic computed tomography showed a low-density liver tumor, enlarged hilar lymph node, and a small nodule on the dorsal side of the lower lobe of the left lung. Histopathological examination of the liver tumor revealed intrahepatic cholangiocarcinoma...
October 2021: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/34085164/efficacy-of-pembrolizumab-in-microsatellite-instability-high-locally-advanced-cholangiocarcinoma-a-case-report
#28
JOURNAL ARTICLE
Katsuya Toshida, Shinji Itoh, Tomoharu Yoshizumi, Tomonari Shimagaki, Huanlin Wang, Takeshi Kurihara, Takeo Toshima, Yoshihiro Nagao, Noboru Harada, Eiji Oki, Yoshiaki Nakamura, Takayuki Yoshino, Masaki Mori
Cholangiocarcinoma is a biliary malignant tumor which can arise at any point of biliary tree. Surgical resection is the only curative treatment and chemotherapy is used for unresectable cases, but its prognosis is poor compared with other types of cancer. Recently, pembrolizumab (PEM), an anti-programmed cell death protein 1 (PD-1) antibody, has become available for microsatellite instability (MSI)-high advanced cancers. Here, we report the use of PEM for MSI-high locally advanced cholangiocarcinoma. A 57-year-old man presented to our department with jaundice...
October 2021: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/33816544/case-report-cytoreductive-surgery-and-hipec-associated-with-liver-electrochemotherapy-in-a-cholangiocarcinoma-patient-with-peritoneal-carcinomatosis-and-liver-metastasis-case-report
#29
Mauro Stefano, Enrico Prosperi, Paola Fugazzola, Beatrice Benini, Marcello Bisulli, Federico Coccolini, Costantino Mastronardi, Alessandro Palladino, Matteo Tomasoni, Vanni Agnoletti, Emanuela Giampalma, Luca Ansaloni
Introduction: Cholangiocarcinoma (CCA) is the second most common primary tumor of the liver, and the recurrence after hepatic resection (HR), the only curative therapy, is linked with a worse prognosis. Systemic chemotherapy (SC) and liver loco-regional treatments, like trans-arterial chemoembolization (TACE) or radio embolization (TARE), have been employed for the treatment of unresectable intrahepatic metastasis (IM) with benefit on overall survival (OS), but SC has a limited effect on peritoneal metastasis (PM)...
2021: Frontiers in Surgery
https://read.qxmd.com/read/33772615/impact-of-18f-fdg-pet-mr-based-tumor-delineation-in-radiotherapy-planning-for-cholangiocarcinoma
#30
JOURNAL ARTICLE
Gauthier Delaby, Bahar Ataeinia, Jennifer Wo, Onofrio Antonio Catalano, Pedram Heidari
PURPOSE: Radiation therapy (RT) is an effective treatment for unresectable cholangiocarcinoma (CC). Accurate tumor volume delineation is critical in achieving high rates of local control while minimizing treatment-related toxicity. This study compares 18 F-FDG PET/MR to MR and CT for target volume delineation for RT planning. METHODS: We retrospectively included 22 patients with newly diagnosed unresectable primary CC who underwent 18 F-FDG PET/MR for initial staging...
March 27, 2021: Abdominal Radiology
https://read.qxmd.com/read/33625678/total-upper-transversal-hepatectomy-with-outflow-reconstruction-for-advanced-mass-forming-cholangiocarcinoma
#31
JOURNAL ARTICLE
Damiano Gentile, Matteo Donadon, Efrem Civilini, Guido Torzilli
We describe a complex case of extended hepatectomy with venous outflow reconstruction for the treatment of advanced mass-forming cholangiocarcinoma (MFCCC) invading the three main hepatic veins (HVs). A 50-year-old woman who received a diagnosis of MFCCC and judged unresectable, was referred to our hospital. After multidisciplinary team evaluation, the patient underwent abdominal computed tomography, gadoxetic acid-enhanced magnetic resonance imaging, and fluorodeoxyglucose positron emission tomography. The radiological examinations showed a large mass located in S4s-8 and S1, in contact with the right hepatic vein (RHV), the inferior right hepatic vein, the anterior wall of the inferior vena cava (IVC), infiltrating the middle and left hepatic veins (MHV, LHV)...
April 2021: Updates in Surgery
https://read.qxmd.com/read/33532258/inter-observer-agreement-of-computed-tomography-and-magnetic-resonance-imaging-on-gross-tumor-volume-delineation-of-intrahepatic-cholangiocarcinoma-an-initial-study
#32
JOURNAL ARTICLE
Nan Zhou, Anning Hu, Zhihao Shi, Xiaolu Wang, Qiongjie Zhu, Qun Zhou, Jun Ma, Feng Zhao, Weiwei Kong, Jian He
Background: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor, and local radiotherapy has a positive effect on patients with an unresectable tumor. Accurate delineation of gross tumor volume (GTV) is crucial to improve the efficacy of radiotherapy. The purpose of this article was to evaluate the consistency of CT, diffusion weighted imaging (DWI) and Gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced MRI on GTV delineation of ICC. Methods: Fourteen patients with ICC underwent CT (Plain and Portal, CT scans before and 70 s after the injection of Omnipaque, respectively), DWI, and Gd-EOB-DTPA-enhanced MRI (EOB 70 s and EOB 15 min, mDIXON scans at 70 s and 15 min after the injection of Gd-EOB-DTPA, respectively) examinations before radiotherapy...
February 2021: Quantitative Imaging in Medicine and Surgery
https://read.qxmd.com/read/33450805/a-population-based-retrospective-study-of-biliary-tract-cancers-in-alberta-canada
#33
JOURNAL ARTICLE
Carissa Beaulieu, Arthur Lui, Dimas Yusuf, Zainab Abdelaziz, Brock Randolph, Eugene Batuyong, Sunita Ghosh, Oliver F Bathe, Vincent Tam, Jennifer L Spratlin
Background: Biliary tract cancers (BTC) are uncommon malignancies and are underrepresented in the literature. Methods: We performed a retrospective population-based review of adult patients with biopsy-confirmed BTC in Alberta from 2000 to 2015. Demographic data, risk factors, symptoms, treatment, and staging data were collected and analyzed. Survival analyses were completed. Results: A total of 1604 patients were included in our study, of which 766 (47.8%) were male. The median age at diagnosis was 68 (range 19-99)...
January 13, 2021: Current Oncology
https://read.qxmd.com/read/32897499/a-case-of-percutaneous-transhepatic-portal-vein-stent-placement-and-endoscopic-injection-sclerotherapy-for-duodenal-variceal-rupture-occurring-during-chemotherapy-for-unresectable-perihilar-cholangiocarcinoma
#34
JOURNAL ARTICLE
Koshiro Fukuda, Takashi Sasaki, Toshiaki Hirasawa, Kiyoshi Matsueda, Eisuke Nakao, Takafumi Mie, Takaaki Furukawa, Yuto Yamada, Tsuyoshi Takeda, Akiyoshi Kasuga, Masato Matsuyama, Masato Ozaka, Naoki Sasahira
Duodenal varices are ectopic varices that are rare but can involve any site along the digestive tract outside the gastroesophageal region. Ectopic variceal bleeding is generally massive and life threatening; the mortality rate is approximately 40%. Up to 17% of ectopic varices occur in the duodenum. However, duodenal varices pose a significant therapeutic challenge due to the lack of standard treatment guidelines. We report a case of duodenal variceal bleeding secondary to portal vein stenosis in a 77-year-old woman receiving chemotherapy for unresectable perihilar cholangiocarcinoma...
December 2020: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/32829371/-a-case-of-unresectable-hilar-cholangiocarcinoma-resected-curatively-through-effective-response-to-neoadjuvant-chemotherapy
#35
JOURNAL ARTICLE
Hiroyuki Imafuji, Yoichi Matsuo, Yoshinaga Aoyama, Tomokatsu Kato, Kan Omi, Yuichi Hayashi, Kenta Saito, Ken Tsuboi, Mamoru Morimoto, Ryo Ogawa, Hiroki Takahashi, Michihiro Yoshida, Itaru Naitoh, Kazuki Hayashi, Shuji Takiguchi
A 60's man came to our hospital for jaundice. Contrast-enhanced CT showed irregular thickening of the hilar bile duct, and the lymph nodes(LN)were swollen from the hilar to the abdominal aorta. These LNs showed similar findings in endoscopic ultrasonography(EUS), and fine needle aspiration cytology(FNA)was performed on the enlarged No.13LN to diagnose LN metastasis of hilar cholangiocarcinoma. Since the peri-aortic LN was also markedly enlarged, it was considered to be metastasis, and was diagnosed as unresectable hilar cholangiocarcinoma with distant LN metastasis...
August 2020: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://read.qxmd.com/read/32753952/efficacy-and-safety-of-apatinib-in-treatment-of-unresectable-intrahepatic-cholangiocarcinoma-an-observational-study
#36
JOURNAL ARTICLE
Yubin Hu, Hailan Lin, Mingzhi Hao, Yan Zhou, Qizhong Chen, Zhangxian Chen
Purpose: Unresectable intrahepatic cholangiocarcinoma (ICC) has a poor prognosis. The aim of this study was to evaluate the efficacy and safety of apatinib for patients with unresectable ICC. Patients and Methods: A total of 10 patients with unresectable ICC were enrolled for this single-center observational study between March 2, 2016, and August 27, 2019. Subjects received 500 mg apatinib on a daily basis. Tumor response was assessed by 1.1 response evaluation criteria in solid tumors...
2020: Cancer Management and Research
https://read.qxmd.com/read/32487639/intraluminal-brachytherapy-in-unresectable-extrahepatic-biliary-duct-cancer-an-italian-pooled-analysis
#37
JOURNAL ARTICLE
Rosa Autorino, Silvia Bisiello, Brigida Pappalardi, Vanessa Privitera, Milly Buwenge, Federica Piccolo, Carlotta Masciocchi, Luca Tagliaferri, Gabriella Macchia, Clelia Delle Curti, Marco Luppatteli, Annamaria Cerrotta, Alessio Giuseppe Morganti, Vincenzo Valentini, Giancarlo Mattiucci
BACKGROUND/AIM: To evaluate the outcome of patients with unresectable extrahepatic cholangiocarcinoma (CC) treated with external-beam radiotherapy (EBRT) and concurrent chemotherapy (CT) with or without intraluminal brachytherapy (ILBT) boost or with definitive ILBT. PATIENTS AND METHODS: A pooled analysis of patients with non-metastatic unresectable CC was performed. They were treated in three different institution with EBRT plus CT with or without an ILBT boost...
June 2020: Anticancer Research
https://read.qxmd.com/read/32295646/relevance-of-suspicious-lymph-nodes-in-preoperative-imaging-for-resectability-recurrence-and-survival-of-intrahepatic-cholangiocarcinoma
#38
JOURNAL ARTICLE
Fabian Bartsch, Felix Hahn, Lukas Müller, Janine Baumgart, Maria Hoppe-Lotichius, Roman Kloeckner, Hauke Lang
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is often diagnosed at an advanced stage resulting in a low resectability rate. Even after potentially curative resection the risk for tumor recurrence is high. Although the extent and value of lymphadenectomy is part of ongoing discussion, the role of preoperative imaging for assessment of suspicious lymph nodes (suspLN) has only been studied modestly. Aim of this study is to demonstrate the influence of suspicious lymph nodes in preoperative imaging on resectability, recurrence, and long-term outcome...
April 15, 2020: BMC Surgery
https://read.qxmd.com/read/32280818/clinical-outcomes-using-magnetic-resonance-guided-stereotactic-body-radiation-therapy-in-patients-with-locally-advanced-cholangiocarcinoma
#39
JOURNAL ARTICLE
Elaine Luterstein, Minsong Cao, James M Lamb, Ann Raldow, Daniel Low, Michael L Steinberg, Percy Lee
Purpose: Previous studies have shown that stereotactic ablative radiation therapy (SABR) increases local control for cholangiocarcinoma, but gastrointestinal toxicity resulting from this treatment approach remains a concern. SABR using magnetic resonance-guided radiation therapy (MRgRT) may improve the therapeutic ratio of treatment for cholangiocarcinoma patients given the radiosensitivity of neighboring gastrointestinal organs. Methods: Seventeen consecutive patients with unresectable locally advanced cholangiocarcinoma were treated with SABR using MRgRT between May 2015 and August 2017, subsequent to our previously reported series of patients treated using a standard Linac with cone beam computed tomography...
March 2020: Advances in Radiation Oncology
https://read.qxmd.com/read/32270353/preliminary-results-in-unresectable-cholangiocarcinoma-treated-by-ct-percutaneous-irreversible-electroporation-feasibility-safety-and-efficacy
#40
JOURNAL ARTICLE
Maria Paola Belfiore, Alfonso Reginelli, Nicola Maggialetti, Mattia Carbone, Sabrina Giovine, Antonella Laporta, Fabrizio Urraro, Valerio Nardone, Roberta Grassi, Salvatore Cappabianca, Luca Brunese
Cholangiocarcinoma (CC) accounts for about 3% of the gastrointestinal and 10-25% of all hepatobiliary malignancies. It arises from the epithelium of the bile duct and it can be classified in intrahaepatic (ICC), perihilar (PCC) and distal (DCC) cholangiocarcinoma, depending on the anatomical location. About 50-60% of the cases are PCC. Early detection is very difficult for the lack of symptoms, and most of the patients are not resectable at the time of diagnosis. IRE is a non-thermal ablation technique that determines cellular apoptosis by electrical impulses without involving extracellular matrix like MW or RF ablation (MWA and RFA)...
April 9, 2020: Medical Oncology
keyword
keyword
158468
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.